Growth Metrics

Tenax Therapeutics (TENX) Current Assets (2016 - 2017)

Historic Current Assets for Tenax Therapeutics (TENX) over the last 6 years, with Q3 2017 value amounting to $8.7 million.

  • Tenax Therapeutics' Current Assets rose 1299.23% to $8.7 million in Q3 2017 from the same period last year, while for Sep 2017 it was $8.7 million, marking a year-over-year increase of 1299.23%. This contributed to the annual value of $13.6 million for FY2016, which is N/A changed from last year.
  • Per Tenax Therapeutics' latest filing, its Current Assets stood at $8.7 million for Q3 2017, which was up 1299.23% from $9.0 million recorded in Q2 2017.
  • Over the past 5 years, Tenax Therapeutics' Current Assets peaked at $20.6 million during Q4 2015, and registered a low of $1.7 million during Q1 2013.
  • Moreover, its 4-year median value for Current Assets was $9.0 million (2017), whereas its average is $9.6 million.
  • In the last 5 years, Tenax Therapeutics' Current Assets crashed by 6186.89% in 2013 and then soared by 1299.23% in 2017.
  • Tenax Therapeutics' Current Assets (Quarter) stood at $1.8 million in 2013, then soared by 1016.05% to $20.6 million in 2015, then tumbled by 33.72% to $13.6 million in 2016, then plummeted by 36.43% to $8.7 million in 2017.
  • Its last three reported values are $8.7 million in Q3 2017, $9.0 million for Q2 2017, and $12.8 million during Q1 2017.